Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1980 Oct 11;281(6246):969–971. doi: 10.1136/bmj.281.6246.969

Thyroxine replacement therapy: prescribing patterns and problems in 2710 patients. Scottish Automated Follow-up Register Group.

PMCID: PMC1714343  PMID: 7427545

Abstract

The use of thyroxine replacement therapy was studied in 2710 patients with a previous diagnosis of either thyrotoxicosis or primary hypothyroidism. The patients, who were treated in five centres, were followed-up continuously using an automated register. Seventy per cent of patients had been prescribed daily doses of thyroxine of 200 microgram or more. The estimated 10-year cumulative incidence of detected undertreatment was 13 . 2% (95% confidence limits 10 . 9-15 .6%). The median cumulative incidence of recognised overtreatment was 6 . 2%. Improved patient education and the dissemination of guidelines to doctors on the use of thyroxine replacement may reduce the incidence of undertreatment or overtreatment.

Full text

PDF
969

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braverman L. E., Ingbar S. H., Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest. 1970 May;49(5):855–864. doi: 10.1172/JCI106304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Evered D., Young E. T., Ormston B. J., Menzies R., Smith P. A., Hall R. Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J. 1973 Jul 21;3(5872):131–134. doi: 10.1136/bmj.3.5872.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Haynes R. B., Sackett D. L., Taylor D. W., Roberts R. S., Johnson A. L. Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions. Clin Pharmacol Ther. 1977 Aug;22(2):125–130. doi: 10.1002/cpt1977222125. [DOI] [PubMed] [Google Scholar]
  4. Hedley A. J., Flemming C. J., Chesters M. I., Michie W., Crooks J. Surgical treatment of thyrotoxicosis. Br Med J. 1970 Feb 28;1(5695):519–523. doi: 10.1136/bmj.1.5695.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hedley A. J., Scott A. M., Debenham G. A computer assisted follow-up register. Methods Inf Med. 1969 Apr;8(2):67–77. [PubMed] [Google Scholar]
  6. Hedley A. J., Scott A. M., Weir R. D., Crooks J. Computer-assisted follow-up register for the north-east of Scotland. Br Med J. 1970 Feb 28;1(5695):556–558. doi: 10.1136/bmj.1.5695.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jackson I. M., Cobb W. E. Why does anyone still use desiccated thyroid USP? Am J Med. 1978 Feb;64(2):284–288. doi: 10.1016/0002-9343(78)90057-8. [DOI] [PubMed] [Google Scholar]
  8. Nilsson G., Pettersson U., Levin K., Hughes R. Studies on replacement and suppressive dosages of 1-thyroxine. Acta Med Scand. 1977;202(4):257–260. doi: 10.1111/j.0954-6820.1977.tb16823.x. [DOI] [PubMed] [Google Scholar]
  9. Tunbridge W. M., Evered D. C., Hall R., Appleton D., Brewis M., Clark F., Evans J. G., Young E., Bird T., Smith P. A. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977 Dec;7(6):481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES